HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1 and other promotility proteins von Singh, M K, Nicolas, E, Gherraby, W, Dadke, D, Lessin, S, Golemis, E A

Volltext

67P Efficacy and safety of trastuzumab biosimilar in HER2+ve metastatic breast cancer: A multicenter phase III study von Mohan, K., Prajapati, A., Kothari, R.K., Mondal, S., R, S., Nagarkar, R., Kane, S.B., Santa, A., Dadke, D.

Volltext

Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle von Dadke, Disha, Jarnik, Michael, Pugacheva, Elena N, Singh, Mahendra K, Golemis, Erica A

Volltext

Activation of p21-activated kinase 1-nuclear factor κB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformation von DADKE, Disha, FRYER, Benjamin H, GOLEMIS, Erica A, FIELD, Jeffrey

Volltext

Protein Interaction-Targeted Drug Discovery: Evaluating Critical Issues von Golemis, Erica A, Tew, Kenneth D, Dadke, Disha

Volltext

The detection of HBV antigens and HBx‐transcripts in an Indian fibrolamellar carcinoma patient: a case study von Dadke, Disha, Jaganath, P., Krishnamurthy, Shanta, Chiplunkar, Shubhada

Volltext

HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1 and other promotility proteins von Singh, M K, Nicolas, E, Gherraby, W, Dadke, D, Lessin, S, Golemis, E A

Volltext

Protein interaction-targeted drug discovery: Evaluating critical issues : Drug discvery and genomic technologies von GOLEMIS, Erica A, TEW, Kenneth D, DADKE, Disha

Volltext